Jing Li is a Senior Scientist at Gilead Sciences, focusing on drug discovery in oncology and cancer immunotherapies. Previously, they served as a Research Scientist at Gilead Sciences from 2021 to 2024 and worked as a Medical Laboratory Scientist at Johns Hopkins University, specializing in PCR-based HIV diagnosis. Jing earned a Doctor of Philosophy (PhD) in Epigenetics and Molecular Carcinogenesis from The University of Texas MD Anderson Cancer Center and completed a postdoctoral fellowship in Cancer Immunology at the University of Michigan. Jing is currently pursuing a Doctor of Medicine (M.D.) degree at Bengbu Medical College.
This person is not in the org chart
This person is not in any teams
This person is not in any offices